logo

For the Inventor, By the Inventor

Lake Villa, IL, United States of America

Thaddeus Stephan Franczyk, Ii

This inventor holds 11 USPTO granted patents. Top assignees: Abbvie Inc., Abbott Laboratories Corporation, Other. Active years: 2012-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thaddeus Stephan Franczyk, Ii. Retrieved from https://idiyas.com/inventor/thaddeus-stephan-franczyk-ii

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11

% Patents Active = 9.1

Average Co-Inventor Count = 6.1

ph-index = 3

Forward Citations = 47(Granted Patents)


Company Filing History:

goldMedal9 out of 826 
 
Abbvie Inc.
 patents
silverMedal1 out of 4,187 
 
Abbott Laboratories Corporation
 patents
bronzeMedal1 out of 834,453 
Other
 patents

Years Active: 2012-2017

Loading Chart...
11 patents (USPTO):Explore Patents
1. 9732045 - Process for preparing antiviral compounds (2017-08-15),
2. 9669399 - Phosphine ligands for catalytic reactions (2017-06-06),
3. 9434698 - Process for preparing antiviral compounds (2016-09-06),
4. 9381508 - Phosphine ligands for catalytic reactions (2016-07-05),
5. 9266913 - Phosphine ligands for catalytic reactions (2016-02-23),
6. 9255074 - Process for preparing antiviral compounds (2016-02-09),
7. 9200021 - Phosphine ligands for catalytic reactions (2015-12-01),
8. 8975443 - Phosphine ligands for catalytic reactions (2015-03-10),
9. 8895737 - Process for preparing antiviral compounds (2014-11-25),
10. 8841487 - Phosphine ligands for catalytic reactions (2014-09-23),
11. 8168784 - Processes to make apoptosis promoters (2012-05-01),

Title: Thaddeus Stephan Franczyk, II: A Leading Innovator in Antiviral and Catalytic Technologies

Introduction

Thaddeus Stephan Franczyk, II, an accomplished inventor based in Lake Villa, IL, holds an impressive portfolio of 11 patents. His innovative work primarily focuses on antiviral compounds and catalytic reactions, showcasing his significant contributions to the field of pharmaceutical chemistry.

Latest Patents

Among his recent innovations, Franczyk’s patents include a groundbreaking process for preparing antiviral compounds aimed at inhibiting the hepatitis C virus (HCV). This disclosure consists of methods for preparing compounds and salts, intermediates for their preparation, pharmaceutical compositions including these compounds, and their methods of use. Another notable patent involves phosphine ligands for catalytic reactions, which covers phosphacycle ligands, catalyst compositions, and methods for utilizing these ligands in bond-forming reactions.

Career Highlights

Thaddeus has made substantial contributions while working at reputed companies such as AbbVie Inc. and Abbott Laboratories Corporation. His expertise in developing innovative solutions has been pivotal in advancing therapeutic technologies and chemical processes within these organizations.

Collaborations

Throughout his career, Franczyk has collaborated with esteemed colleagues, including Anthony Ralph Haight and Shashank Shekhar. These partnerships have undoubtedly enriched his work and broadened the impact of his inventions in the research community.

Conclusion

Thaddeus Stephan Franczyk, II exemplifies the spirit of innovation through his dedication to developing novel antiviral and catalytic technologies. With 11 patents to his name and a successful career in pharmaceuticals, he continues to make significant strides in the field, paving the way for future advancements in healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…